Cargando…
Cerebral White Matter Hyperintensities, Kidney Function Decline, and Recurrent Stroke After Intensive Blood Pressure Lowering: Results From the Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
BACKGROUND: We aimed to determine whether cerebral white matter hyperintensities (WMHs) can distinguish stroke survivors susceptible to rapid kidney function decline from intensive blood pressure (BP) lowering. METHODS AND RESULTS: The SPS3 (Secondary Prevention of Small Subcortical Strokes) trial r...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405594/ https://www.ncbi.nlm.nih.gov/pubmed/30686103 http://dx.doi.org/10.1161/JAHA.118.010091 |
_version_ | 1783401107874119680 |
---|---|
author | Ikeme, Jesse C. Pergola, Pablo E. Scherzer, Rebecca Shlipak, Michael G. Catanese, Luciana McClure, Leslie A. Benavente, Oscar R. Peralta, Carmen A. |
author_facet | Ikeme, Jesse C. Pergola, Pablo E. Scherzer, Rebecca Shlipak, Michael G. Catanese, Luciana McClure, Leslie A. Benavente, Oscar R. Peralta, Carmen A. |
author_sort | Ikeme, Jesse C. |
collection | PubMed |
description | BACKGROUND: We aimed to determine whether cerebral white matter hyperintensities (WMHs) can distinguish stroke survivors susceptible to rapid kidney function decline from intensive blood pressure (BP) lowering. METHODS AND RESULTS: The SPS3 (Secondary Prevention of Small Subcortical Strokes) trial randomized participants with recent lacunar stroke to systolic BP targets of 130 to 149 and <130 mm Hg. We included 2454 participants with WMH measured by clinical magnetic resonance imaging at baseline and serum creatinine measured during follow‐up. We tested interactions between BP target and WMH burden on the incidence of rapid kidney function decline (≥30% decrease from baseline estimated glomerular filtration rate at 1‐year follow‐up) and recurrent stroke. Rapid kidney function decline incidence was 11.0% in the lower‐BP‐target arm and 8.1% in the higher‐target arm (odds ratio=1.40; 95% CI=1.07–1.84). Odds ratio for rapid kidney function decline between lower‐ and higher‐target groups ranged from 1.26 in the lowest WMH tertile (95% CI, 0.80–1.98) to 1.71 in the highest tertile (95% CI, 1.05–2.80; P for interaction=0.65). Overall incidence of recurrent stroke was 7.9% in the lower‐target arm and 9.6% in the higher‐target arm (hazard ratio=0.80; 95% CI, 0.63–1.03). Hazard ratio for recurrent stroke in the lower‐target group was 1.13 (95% CI, 0.73–1.75) within the lowest WMH tertile compared with 0.73 (95% CI, 0.49–1.09) within the highest WMH tertile (P for interaction=0.04). CONCLUSIONS: Participants with higher WMH burden appeared to experience greater benefit from intensive BP lowering in prevention of recurrent stroke. By contrast, intensive BP lowering increased the odds of kidney function decline, but WMH burden did not significantly distinguish this risk. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00059306. |
format | Online Article Text |
id | pubmed-6405594 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-64055942019-03-21 Cerebral White Matter Hyperintensities, Kidney Function Decline, and Recurrent Stroke After Intensive Blood Pressure Lowering: Results From the Secondary Prevention of Small Subcortical Strokes (SPS3) Trial Ikeme, Jesse C. Pergola, Pablo E. Scherzer, Rebecca Shlipak, Michael G. Catanese, Luciana McClure, Leslie A. Benavente, Oscar R. Peralta, Carmen A. J Am Heart Assoc Original Research BACKGROUND: We aimed to determine whether cerebral white matter hyperintensities (WMHs) can distinguish stroke survivors susceptible to rapid kidney function decline from intensive blood pressure (BP) lowering. METHODS AND RESULTS: The SPS3 (Secondary Prevention of Small Subcortical Strokes) trial randomized participants with recent lacunar stroke to systolic BP targets of 130 to 149 and <130 mm Hg. We included 2454 participants with WMH measured by clinical magnetic resonance imaging at baseline and serum creatinine measured during follow‐up. We tested interactions between BP target and WMH burden on the incidence of rapid kidney function decline (≥30% decrease from baseline estimated glomerular filtration rate at 1‐year follow‐up) and recurrent stroke. Rapid kidney function decline incidence was 11.0% in the lower‐BP‐target arm and 8.1% in the higher‐target arm (odds ratio=1.40; 95% CI=1.07–1.84). Odds ratio for rapid kidney function decline between lower‐ and higher‐target groups ranged from 1.26 in the lowest WMH tertile (95% CI, 0.80–1.98) to 1.71 in the highest tertile (95% CI, 1.05–2.80; P for interaction=0.65). Overall incidence of recurrent stroke was 7.9% in the lower‐target arm and 9.6% in the higher‐target arm (hazard ratio=0.80; 95% CI, 0.63–1.03). Hazard ratio for recurrent stroke in the lower‐target group was 1.13 (95% CI, 0.73–1.75) within the lowest WMH tertile compared with 0.73 (95% CI, 0.49–1.09) within the highest WMH tertile (P for interaction=0.04). CONCLUSIONS: Participants with higher WMH burden appeared to experience greater benefit from intensive BP lowering in prevention of recurrent stroke. By contrast, intensive BP lowering increased the odds of kidney function decline, but WMH burden did not significantly distinguish this risk. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00059306. John Wiley and Sons Inc. 2019-01-26 /pmc/articles/PMC6405594/ /pubmed/30686103 http://dx.doi.org/10.1161/JAHA.118.010091 Text en © 2019 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Research Ikeme, Jesse C. Pergola, Pablo E. Scherzer, Rebecca Shlipak, Michael G. Catanese, Luciana McClure, Leslie A. Benavente, Oscar R. Peralta, Carmen A. Cerebral White Matter Hyperintensities, Kidney Function Decline, and Recurrent Stroke After Intensive Blood Pressure Lowering: Results From the Secondary Prevention of Small Subcortical Strokes (SPS3) Trial |
title | Cerebral White Matter Hyperintensities, Kidney Function Decline, and Recurrent Stroke After Intensive Blood Pressure Lowering: Results From the Secondary Prevention of Small Subcortical Strokes (SPS3) Trial |
title_full | Cerebral White Matter Hyperintensities, Kidney Function Decline, and Recurrent Stroke After Intensive Blood Pressure Lowering: Results From the Secondary Prevention of Small Subcortical Strokes (SPS3) Trial |
title_fullStr | Cerebral White Matter Hyperintensities, Kidney Function Decline, and Recurrent Stroke After Intensive Blood Pressure Lowering: Results From the Secondary Prevention of Small Subcortical Strokes (SPS3) Trial |
title_full_unstemmed | Cerebral White Matter Hyperintensities, Kidney Function Decline, and Recurrent Stroke After Intensive Blood Pressure Lowering: Results From the Secondary Prevention of Small Subcortical Strokes (SPS3) Trial |
title_short | Cerebral White Matter Hyperintensities, Kidney Function Decline, and Recurrent Stroke After Intensive Blood Pressure Lowering: Results From the Secondary Prevention of Small Subcortical Strokes (SPS3) Trial |
title_sort | cerebral white matter hyperintensities, kidney function decline, and recurrent stroke after intensive blood pressure lowering: results from the secondary prevention of small subcortical strokes (sps3) trial |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405594/ https://www.ncbi.nlm.nih.gov/pubmed/30686103 http://dx.doi.org/10.1161/JAHA.118.010091 |
work_keys_str_mv | AT ikemejessec cerebralwhitematterhyperintensitieskidneyfunctiondeclineandrecurrentstrokeafterintensivebloodpressureloweringresultsfromthesecondarypreventionofsmallsubcorticalstrokessps3trial AT pergolapabloe cerebralwhitematterhyperintensitieskidneyfunctiondeclineandrecurrentstrokeafterintensivebloodpressureloweringresultsfromthesecondarypreventionofsmallsubcorticalstrokessps3trial AT scherzerrebecca cerebralwhitematterhyperintensitieskidneyfunctiondeclineandrecurrentstrokeafterintensivebloodpressureloweringresultsfromthesecondarypreventionofsmallsubcorticalstrokessps3trial AT shlipakmichaelg cerebralwhitematterhyperintensitieskidneyfunctiondeclineandrecurrentstrokeafterintensivebloodpressureloweringresultsfromthesecondarypreventionofsmallsubcorticalstrokessps3trial AT cataneseluciana cerebralwhitematterhyperintensitieskidneyfunctiondeclineandrecurrentstrokeafterintensivebloodpressureloweringresultsfromthesecondarypreventionofsmallsubcorticalstrokessps3trial AT mcclurelesliea cerebralwhitematterhyperintensitieskidneyfunctiondeclineandrecurrentstrokeafterintensivebloodpressureloweringresultsfromthesecondarypreventionofsmallsubcorticalstrokessps3trial AT benaventeoscarr cerebralwhitematterhyperintensitieskidneyfunctiondeclineandrecurrentstrokeafterintensivebloodpressureloweringresultsfromthesecondarypreventionofsmallsubcorticalstrokessps3trial AT peraltacarmena cerebralwhitematterhyperintensitieskidneyfunctiondeclineandrecurrentstrokeafterintensivebloodpressureloweringresultsfromthesecondarypreventionofsmallsubcorticalstrokessps3trial |